Staphylococcus aureus persistence in non-professional phagocytes

International Journal of Medical Microbiology : IJMM
Bettina LöfflerG Peters

Abstract

S. aureus is a frequent cause of chronic and therapy-refractory infections. The ability of S. aureus to invade different types of non-professional phagocytes, to escape from the host lysosomal degradation machinery and to persist within the intracellular location for long time periods are most likely essential steps in pathogenesis. During the course from acute to chronic infection the bacteria need to dynamically react to the environmental changes and to adapt to the intracellular environment. In this context the bacteria change to SCV-like phenotypes that exhibit some characteristics of stable SCV-mutants, like upregulation of adhesins and downregulation of toxins. The exact formation mechanism and further typical features of these dynamically forming SCVs are largely unknown. In this review, recent data on the essential steps to establish chronic infections will be summarized and the clinical consequences of the dynamic bacterial adaptation mechanisms will be discussed.

References

Feb 1, 1988·Journal of Ultrastructure and Molecular Structure Research·F D LowyV B Hatcher
Jan 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A ProctorR D Arbeit
Mar 1, 1996·The Journal of Infectious Diseases·O VesgaR A Proctor
Jan 9, 1999·The New England Journal of Medicine·S BlotF Colardyn
Feb 26, 1999·Trends in Microbiology·T J Foster, M Höök
Oct 21, 1999·Microbiology and Immunology·M MuraiS Masuda
Feb 23, 2000·FEMS Immunology and Medical Microbiology·I NuzzoC R Carratelli
Sep 1, 2000·FEMS Immunology and Medical Microbiology·B E Menzies, I Kourteva
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C von EiffG Peters
Sep 14, 2002·Infection and Immunity·Ruth C MasseySharon J Peacock
Jan 14, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Nicole BaumertHans-Georg Sahl
Jan 20, 2004·The Journal of Antimicrobial Chemotherapy·Oleg KrutMartin Krönke
Jan 22, 2004·FEMS Immunology and Medical Microbiology·Ambrose L CheungYan-Qiong Xiong
Jul 28, 2004·Lancet·Daniel P Lew, Francis A Waldvogel
Sep 24, 2004·Infection and Immunity·Sompid KintarakSean P Nair
Jul 13, 2005·Cellular Microbiology·Bettina Haslinger-LöfflerBhanu Sinha
Aug 16, 2005·Trends in Immunology·Vojo Deretic
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Christof von EiffGeorg Peters
Nov 29, 2005·Journal of Chemical Information and Modeling·Mauro Dalla SerraGilles Prévost
Feb 24, 2006·Antimicrobial Agents and Chemotherapy·Maritza Barcia-MacayFrançoise Van Bambeke
Mar 17, 2006·Nature Reviews. Microbiology·Richard A ProctorGeorg Peters
Dec 1, 2006·The Journal of Biological Chemistry·Annabelle SchnaithOleg Krut
Aug 30, 2008·The Journal of Infectious Diseases·Bo ShopsinRichard P Novick
Jan 24, 2009·Trends in Microbiology·Parham Sendi, Richard A Proctor
Mar 24, 2009·Biochimica Et Biophysica Acta·Emanuel Campoy, María I Colombo
Nov 6, 2009·Cellular Microbiology·María C LerenaMaría I Colombo

❮ Previous
Next ❯

Citations

Jan 28, 2014·International Journal of Medical Microbiology : IJMM·Barbara M BrökerIsabelle Bekeredjian-Ding
Jan 21, 2014·International Journal of Medical Microbiology : IJMM·Barbara Bröker, Michael Hecker
Aug 5, 2015·Nucleic Acids Research·Hélène Le PabicBrice Felden
Mar 22, 2016·Pathogens·Barbara M BrökerVincent Péton
Jul 26, 2016·Frontiers in Cellular and Infection Microbiology·Jérôme JosseSophie C Gangloff
Jul 10, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M StrobelS Niemann
Jan 28, 2017·Trends in Molecular Medicine·Sanjeev Mariathasan, Man-Wah Tan
Mar 14, 2018·Microorganisms·Pietro SpezialeGiampiero Pietrocola
Mar 24, 2018·Future Medicinal Chemistry·Wooseong KimEleftherios Mylonakis
Dec 21, 2017·Frontiers in Microbiology·Jérôme JosseAlan Diot
Dec 3, 2014·Antimicrobial Agents and Chemotherapy·Justin R LenhardBrian T Tsuji
Nov 3, 2015·Analytical and Bioanalytical Chemistry·Rabeay Y A Hassan, Ulla Wollenberger
Jun 1, 2018·Nature Reviews. Disease Primers·Andie S LeeStephan Harbarth
Nov 25, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Samar SayedyahosseinLina Dagnino
Aug 5, 2017·Frontiers in Microbiology·Guillaume RollinMathieu Coureuil
Jul 23, 2020·Frontiers in Microbiology·Nicola HäffnerAnnelies S Zinkernagel
Sep 3, 2020·International Journal of Molecular Sciences·Alan DiotFrédéric Laurent
Dec 26, 2018·Journal of Dairy Science·Julie Côté-Gravel, François Malouin
Feb 6, 2017·Environmental Toxicology·Eun-Jung ParkDong-Wan Kim
May 14, 2018·Journal of Dairy Science·C SartoriH U Graber
Aug 10, 2019·Frontiers in Immunology·Elisabeth Seebach, Katharina F Kubatzky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.